Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 19];7(2):s109. Available from: https://skin.dermsquared.com/skin/article/view/1982